<?xml version="1.0" encoding="ISO-8859-1"?>
<MetaStudyForm>
	<Row StudyFormId="1" FormId="204" FormTitle="Helseopplysninger" StudyName="LINDBERGS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="2" FormId="209" FormTitle="Arbeidsmiljø" StudyName="LINDBERGS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="3" FormId="216" FormTitle="Kostvaner" StudyName="LINDBERGS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="4" FormId="244" FormTitle="IPAQ" StudyName="LINDBERGS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="5" FormId="164" FormTitle="MADRS" StudyName="FENGSEL" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="6" FormId="215" FormTitle="Mottaksjournal" StudyName="FENGSEL" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="7" FormId="290" FormTitle="Demografi" StudyName="FENGSEL" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="8" FormId="291" FormTitle="Løslatelse" StudyName="FENGSEL" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="9" FormId="292" FormTitle="Kriminalitet" StudyName="FENGSEL" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="10" FormId="293" FormTitle="Rusmiddelbruk" StudyName="FENGSEL" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="11" FormId="155" FormTitle="Prime-MD selvutfylling" StudyName="ALLRATE" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="12" FormId="159" FormTitle="MMS - Mini Mental Status" StudyName="ALLRATE" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="13" FormId="164" FormTitle="MADRS" StudyName="ALLRATE" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="14" FormId="262" FormTitle="GDS depresjonsskala" StudyName="ALLRATE" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="15" FormId="325" FormTitle="Barthel ADL-indeks" StudyName="ALLRATE" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="16" FormId="379" FormTitle="Cornell depresjonskala" StudyName="ALLRATE" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="17" FormId="407" FormTitle="DES - Dissosiasjons Erfarings Skala" StudyName="ALLRATE" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="18" FormId="435" FormTitle="MMSE-NR" StudyName="ALLRATE" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-12-01T14:16:29.073Z"/>
	<Row StudyFormId="19" FormId="106" FormTitle="Administrative data" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="20" FormId="109" FormTitle="Anamnese" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="21" FormId="113" FormTitle="Status presens" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="22" FormId="142" FormTitle="Hulten pleietyngde" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="23" FormId="146" FormTitle="Infeksjonsregistrering" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="24" FormId="149" FormTitle="Epikrise til fastlegen" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="25" FormId="159" FormTitle="MMS - Mini Mental Status" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="26" FormId="160" FormTitle="ESAS" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="27" FormId="161" FormTitle="Berger demensgrad" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="28" FormId="164" FormTitle="MADRS" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="29" FormId="169" FormTitle="Sykehusinnleggelse" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="30" FormId="175" FormTitle="CAM - delirvurdering " StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="31" FormId="198" FormTitle="Notat sykepleier" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="32" FormId="261" FormTitle="Journalnotat" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="33" FormId="262" FormTitle="GDS depresjonsskala" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="34" FormId="265" FormTitle="Retur fra sykehus" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="35" FormId="266" FormTitle="Dødsattest" StudyName="GBD" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="36" FormId="267" FormTitle="Skade/fall" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="37" FormId="269" FormTitle="EKG beskrivelse" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="38" FormId="270" FormTitle="Telefonsamtale pårørende" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="39" FormId="271" FormTitle="Notat, lege" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="40" FormId="272" FormTitle="Møte pårørende" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="41" FormId="273" FormTitle="Årskontroll" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="42" FormId="274" FormTitle="Fallrisiko" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="43" FormId="275" FormTitle="Epikrise fra innleggelse" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="44" FormId="276" FormTitle="Epikrise fra poliklinikk" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="45" FormId="279" FormTitle="Epikrise fra bildeundersøkelse" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="46" FormId="282" FormTitle="Berger demensgrad" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="47" FormId="283" FormTitle="Marevan-dosering" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="48" FormId="297" FormTitle="Labrekvisisjon" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="49" FormId="311" FormTitle="Henvisning" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="0" LastUpdate="2016-06-17T14:44:12.083Z"/>
	<Row StudyFormId="50" FormId="312" FormTitle="EKG beskrivelse" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="51" FormId="315" FormTitle="Epikrise til andre" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="52" FormId="316" FormTitle="Beslutninger" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="53" FormId="317" FormTitle="Administrasjon" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="54" FormId="319" FormTitle="Insulindosering" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="55" FormId="324" FormTitle="Kurvenotat" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="56" FormId="325" FormTitle="Barthel ADL-indeks" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="57" FormId="326" FormTitle="Stellebeskrivelse" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="58" FormId="327" FormTitle="Enkelt sykepleienotat" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="59" FormId="328" FormTitle="Lokale labdata" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="60" FormId="329" FormTitle="Enkelt legenotat" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="61" FormId="330" FormTitle="Enkelt pleienotat" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="62" FormId="331" FormTitle="Anamnese" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="63" FormId="332" FormTitle="Sosial anamnese" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="64" FormId="342" FormTitle="MDS 3.0 Section K" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="65" FormId="343" FormTitle="NPI-Q Kortversjon" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="66" FormId="358" FormTitle="Tvangsvedtak" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="67" FormId="359" FormTitle="Demens - medikamenteffekt" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="68" FormId="360" FormTitle="Sonder og katetre" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="69" FormId="375" FormTitle="Labrekvisisjon LKB" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="70" FormId="379" FormTitle="Cornell depresjonskala" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="71" FormId="380" FormTitle="OBS Demens" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="72" FormId="386" FormTitle="Status presens" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="73" FormId="388" FormTitle="EKG beskrivelse" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="74" FormId="391" FormTitle="Epikrise, mottatt elektronisk" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="75" FormId="401" FormTitle="MNA - Mini Nutritional Assessment" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="76" FormId="402" FormTitle="Kostregistrering ved innkomst" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="77" FormId="403" FormTitle="MUST - Underernæring" StudyName="GBD" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="78" FormId="406" FormTitle="Insulindosering" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="79" FormId="408" FormTitle="Sårprosedyre" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="80" FormId="410" FormTitle="Innhenting av fastlege-opplysninger" StudyName="GBD" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="81" FormId="411" FormTitle="Ernæringstiltak" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="82" FormId="412" FormTitle="Braden trykksår-risiko" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="83" FormId="413" FormTitle="Innkomstsamtale (korttid)" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-21T08:56:55.060Z"/>
	<Row StudyFormId="84" FormId="414" FormTitle="Innkomstsamtale" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="85" FormId="416" FormTitle="LCP - Oppstart" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="86" FormId="417" FormTitle="LCP - Fortløpende vurderinger" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="87" FormId="418" FormTitle="Mors - sjekkliste (inkl. LCP del 3)" StudyName="GBD" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="88" FormId="428" FormTitle="Matkort" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="89" FormId="435" FormTitle="MMSE-NR" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-12-01T14:16:29.073Z"/>
	<Row StudyFormId="90" FormId="441" FormTitle="Wells score DVT" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="91" FormId="443" FormTitle="Sjekkliste før innkomst (langtidsplass)" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="92" FormId="444" FormTitle="Sjekkliste etter innkomst (langtidsplass)" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="93" FormId="445" FormTitle="Vaktmester-kontroll av eksternt elektrisk utstyr" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="94" FormId="446" FormTitle="Pårørendesamtale (invitasjon)" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="95" FormId="447" FormTitle="Oppfølgingssamtale" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="96" FormId="448" FormTitle="Innkomstsamtale (langtid)" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="97" FormId="449" FormTitle="Kostsamtale ved innkomst" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="98" FormId="450" FormTitle="Aktivitetsplan" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-21T09:53:08.550Z"/>
	<Row StudyFormId="99" FormId="451" FormTitle="Vekt" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="100" FormId="452" FormTitle="Samarbeidsavtale med beboer/pårørende" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="101" FormId="455" FormTitle="Påminnelse" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-06-30T12:36:34.700Z"/>
	<Row StudyFormId="102" FormId="456" FormTitle="Sykepleierapport" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="103" FormId="457" FormTitle="MDS 3.0 Section K - Swallowing and Nutritional Status" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="104" FormId="458" FormTitle="Tannstatus" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-21T09:10:19.123Z"/>
	<Row StudyFormId="105" FormId="459" FormTitle="Stellebeskrivelse" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="106" FormId="294" FormTitle="Konsultasjon" StudyName="VANKY" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="107" FormId="300" FormTitle="Fastlege" StudyName="VANKY" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="108" FormId="364" FormTitle="Kontaktinformasjon" StudyName="VANKY" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="109" FormId="377" FormTitle="Epikrise til fastlegen" StudyName="VANKY" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="110" FormId="378" FormTitle="Henvisning" StudyName="VANKY" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="112" FormId="252" FormTitle="Poliklinisk kontroll" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="113" FormId="254" FormTitle="Fotstatus" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="114" FormId="255" FormTitle="Øyestatus" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="115" FormId="256" FormTitle="Opplæring diabetes" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="116" FormId="257" FormTitle="Laboratoriedata" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="117" FormId="258" FormTitle="NDV Årsrapport" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="118" FormId="289" FormTitle="Insulindosering" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="119" FormId="295" FormTitle="Insulinpumpe" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="120" FormId="298" FormTitle="PAID - Problemområder i Diabetes" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="121" FormId="299" FormTitle="Grunndata" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="122" FormId="302" FormTitle="Komplikasjoner" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="123" FormId="303" FormTitle="Behandlingsmål" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="124" FormId="304" FormTitle="Blodtrykk 24-timer" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="125" FormId="305" FormTitle="Svangerskapskontroll" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="126" FormId="309" FormTitle="Årskontroll" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="127" FormId="310" FormTitle="Telefonisk kontakt" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="128" FormId="314" FormTitle="Insulindosering" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="129" FormId="318" FormTitle="Poliklinisk kontroll" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="130" FormId="319" FormTitle="Insulindosering" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="131" FormId="320" FormTitle="Årskontroll" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="132" FormId="321" FormTitle="Poliklinisk kontroll" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="133" FormId="361" FormTitle="Poliklinisk kontroll" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="134" FormId="362" FormTitle="Grunndata diabetes" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="135" FormId="363" FormTitle="Årskontroll" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="136" FormId="387" FormTitle="Fotstatus" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="137" FormId="393" FormTitle="Årskontroll" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="138" FormId="404" FormTitle="Epworth Sleepiness Scale" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="139" FormId="406" FormTitle="Insulindosering" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="140" FormId="409" FormTitle="Årskontroll" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="141" FormId="306" FormTitle="Registreringsskjema" StudyName="MS" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="142" FormId="307" FormTitle="Start av immunmodulerende behandling" StudyName="MS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="143" FormId="308" FormTitle="Oppfølging/endring av immunmodulerende behandling" StudyName="MS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="144" FormId="340" FormTitle="test_jan" StudyName="MS" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="145" FormId="322" FormTitle="Praksisdata" StudyName="EMETRA" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="146" FormId="323" FormTitle="Installasjon" StudyName="EMETRA" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="147" FormId="383" FormTitle="Tre spørsmål om Argus" StudyName="EMETRA" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="148" FormId="384" FormTitle="Argus utsendelse" StudyName="EMETRA" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="149" FormId="399" FormTitle="Telefonsupport" StudyName="EMETRA" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="150" FormId="419" FormTitle="Installasjonsopplysninger" StudyName="EMETRA" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="151" FormId="342" FormTitle="MDS 3.0 Section K" StudyName="MDS30" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="152" FormId="457" FormTitle="MDS 3.0 Section K - Swallowing and Nutritional Status" StudyName="MDS30" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="158" FormId="382" FormTitle="Årskontroll Web" StudyName="NDV.MRS" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="159" FormId="394" FormTitle="Blodtrykksmidler" StudyName="NDV.MRS" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="160" FormId="396" FormTitle="Antidiabetisk behandling" StudyName="NDV.MRS" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="161" FormId="389" FormTitle="Antidiabetisk behandling" StudyName="MEDISINER" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="162" FormId="394" FormTitle="Blodtrykksmidler" StudyName="MEDISINER" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="163" FormId="397" FormTitle="Lipidsenkende midler" StudyName="MEDISINER" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="164" FormId="398" FormTitle="Platehemmere" StudyName="MEDISINER" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="165" FormId="392" FormTitle="Primærhelsetjeneste" StudyName="NDV.PHT" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="166" FormId="419" FormTitle="Installasjonsopplysninger" StudyName="UNO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="167" FormId="420" FormTitle="Ny versjon" StudyName="UNO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="168" FormId="421" FormTitle="Fjerntilgang" StudyName="UNO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="169" FormId="422" FormTitle="Superbruker" StudyName="UNO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="170" FormId="423" FormTitle="Telefonsamtale" StudyName="UNO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="171" FormId="424" FormTitle="Epostmelding" StudyName="UNO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="172" FormId="411" FormTitle="Ernæringstiltak" StudyName="GBD.KOST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="173" FormId="428" FormTitle="Matkort" StudyName="GBD.KOST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="174" FormId="449" FormTitle="Kostsamtale ved innkomst" StudyName="GBD.KOST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="175" FormId="463" FormTitle="Addisons sykdom" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="176" FormId="465" FormTitle="Innkomstsamtale langtid" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="178" FormId="466" FormTitle="CTS Preop vurdering" StudyName="HAND" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="179" FormId="467" FormTitle="Kvikk-DASH, CTS Preop" StudyName="HAND" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="180" FormId="464" FormTitle="Tannstatus" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="181" FormId="468" FormTitle="Årskontroll diabetes" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="182" FormId="469" FormTitle="Poliklinisk kontroll" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="185" FormId="470" FormTitle="Pasientskjema" StudyName="NDV.PAS" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="186" FormId="392" FormTitle="Primærhelsetjeneste" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="187" FormId="471" FormTitle="Endotumor grunnskjema" StudyName="ENDO.TUMOR" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="188" FormId="472" FormTitle="Inclusion (old)" StudyName="BAR" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="189" FormId="473" FormTitle="QUALID - Livskvalitet ved langtkommen demens" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="190" FormId="475" FormTitle="CTS Operasjon" StudyName="HAND" ParentId="466" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="191" FormId="476" FormTitle="Sykehusinnleggelse" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="192" FormId="460" FormTitle="Sjekkliste under korttidsopphold" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="193" FormId="461" FormTitle="Sjekkliste ved utreise (korttid)" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="194" FormId="480" FormTitle="Endotumor Symptomer" StudyName="ENDO.TUMOR" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="195" FormId="481" FormTitle="Endotumor Kliniske funn" StudyName="ENDO.TUMOR" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="196" FormId="482" FormTitle="Endotumor Blodprøver" StudyName="ENDO.TUMOR" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="197" FormId="483" FormTitle="Poliklinisk kontroll" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="198" FormId="484" FormTitle="Boston Questionnaire" StudyName="HAND" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="200" FormId="489" FormTitle="Kliniske data" StudyName="ROAS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="201" FormId="490" FormTitle="SF-36 Resultat" StudyName="ROAS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="202" FormId="491" FormTitle="Symptomdiagnoser" StudyName="ROAS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="204" FormId="492" FormTitle="Labprøver" StudyName="ROAS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="206" FormId="494" FormTitle="Demografi" StudyName="ROAS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="207" FormId="495" FormTitle="Antistoffer" StudyName="ROAS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="208" FormId="496" FormTitle="Diabetes diagnose" StudyName="ROAS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="209" FormId="497" FormTitle="Fryseprøver" StudyName="ROAS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="210" FormId="498" FormTitle="Startskjema" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="211" FormId="498" FormTitle="Startskjema" StudyName="NDV.PHT" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="212" FormId="499" FormTitle="Oppfølging" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="213" FormId="499" FormTitle="Oppfølging" StudyName="NDV.PHT" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="214" FormId="500" FormTitle="Addison diagnose" StudyName="ROAS" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="215" FormId="501" FormTitle="Død" StudyName="ROAS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="216" FormId="502" FormTitle="Kliniske data og SF-36" StudyName="ROAS" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="217" FormId="503" FormTitle="Notat" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-05-04T12:17:17.227Z"/>
	<Row StudyFormId="218" FormId="504" FormTitle="Innkomstsamtale (langtid)" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-21T10:51:26.307Z"/>
	<Row StudyFormId="219" FormId="505" FormTitle="Musikkterapi" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="220" FormId="506" FormTitle="MDS 3.0 Section C - Cogntive Patterns" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="221" FormId="458" FormTitle="Tannstatus" StudyName="MDS30" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-21T09:10:19.123Z"/>
	<Row StudyFormId="222" FormId="506" FormTitle="MDS 3.0 Section C - Cogntive Patterns" StudyName="MDS30" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="223" FormId="524" FormTitle="SF-36 Detaljert norsk kladd" StudyName="BAR" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="224" FormId="508" FormTitle="Aneurysm details" StudyName="BAR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="225" FormId="507" FormTitle="Treatment details (shared)" StudyName="BAR" ParentId="508" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="226" FormId="509" FormTitle="Day 7 or departure" StudyName="BAR" ParentId="655" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="228" FormId="510" FormTitle="Barthel Index - Admission" StudyName="BAR" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="231" FormId="513" FormTitle="LCP del 2 - Fortløpende vurderinger" StudyName="GBD" ParentId="528" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="232" FormId="514" FormTitle="Mors (LCP del 3 - ved dødsfallet)" StudyName="GBD" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="233" FormId="515" FormTitle="LCP del 1a - Første vurdering" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="234" FormId="516" FormTitle="Epikrise til legetjenesten (Profil)" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="235" FormId="517" FormTitle="Euradrenal registration" StudyName="ROAS" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="236" FormId="518" FormTitle="Discharge (First Admission)" StudyName="BAR" ParentId="655" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="237" FormId="520" FormTitle="Fotstatus" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="238" FormId="521" FormTitle="Avviksregistrering" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="239" FormId="477" FormTitle="Bestemmelse av resturin med blærescanning" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="240" FormId="523" FormTitle="Glasgow Benefit Inventory - Day 90" StudyName="BAR" ParentId="526" Repeatable="0" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="241" FormId="525" FormTitle="Day 90" StudyName="BAR" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="242" FormId="526" FormTitle="Day 365" StudyName="BAR" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="244" FormId="528" FormTitle="LCP del 1b - Første vurdering (fortsettelse)" StudyName="GBD" ParentId="515" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="245" FormId="362" FormTitle="Grunndata diabetes" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="246" FormId="468" FormTitle="Årskontroll diabetes" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="247" FormId="469" FormTitle="Poliklinisk kontroll" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="248" FormId="529" FormTitle="Bakgrunn - Autoimmunitet" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="249" FormId="494" FormTitle="Demografi" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="250" FormId="530" FormTitle="Endokrin substitusjonsbehandling" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="252" FormId="531" FormTitle="Autoimmunitet i familien" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="253" FormId="532" FormTitle="Thyroideasykdom" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="254" FormId="533" FormTitle="Hypoparatyreoidisme" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="255" FormId="534" FormTitle="Insulinbehandling" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="256" FormId="534" FormTitle="Insulinbehandling" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="258" FormId="462" FormTitle="Demografiske data" StudyName="FEDME" Repeatable="0" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="259" FormId="537" FormTitle="Kliniske parametre" StudyName="FEDME" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="260" FormId="538" FormTitle="Operasjonsdata" StudyName="FEDME" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="261" FormId="539" FormTitle="IWQoL-Lite" StudyName="FEDME" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="262" FormId="540" FormTitle="Bariatriske blodprøver" StudyName="FEDME" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="263" FormId="541" FormTitle="HAD - Hospital Anxiety and Depression Scale" StudyName="FEDME" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="264" FormId="543" FormTitle="Første besøk" StudyName="FEDME" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="265" FormId="544" FormTitle="Preoperativt" StudyName="FEDME" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="266" FormId="545" FormTitle="Computertomografi" StudyName="GBD" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="267" FormId="474" FormTitle="Kostregistrering 2 dager" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="268" FormId="546" FormTitle="Epikrise til hjemmesykepleien (Profil)" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="269" FormId="547" FormTitle="Barthel Index - Day 7 or discharge" StudyName="BAR" ParentId="509" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="270" FormId="548" FormTitle="Barthel Index - Day 90" StudyName="BAR" ParentId="525" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="271" FormId="549" FormTitle="Barthel Index - 1 year" StudyName="BAR" ParentId="526" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="272" FormId="550" FormTitle="Treatment details (per aneurysm)" StudyName="BAR" ParentId="507" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="273" FormId="490" FormTitle="SF-36 Resultat" StudyName="BAR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="274" FormId="529" FormTitle="Bakgrunn - Autoimmunitet" StudyName="ROAS" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="276" FormId="554" FormTitle="NIH Stroke Scale" StudyName="BAR" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="277" FormId="555" FormTitle="Grunnskjema" StudyName="OVERVEKT" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="279" FormId="556" FormTitle="Poliklinisk besøk" StudyName="OVERVEKT" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="280" FormId="557" FormTitle="Brev" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="281" FormId="558" FormTitle="Bestemmelse av resturin med blærescanning v2" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="285" FormId="563" FormTitle="Addison Livskvalitet" StudyName="ROAS" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="287" FormId="562" FormTitle="Genotyper" StudyName="ROAS" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="289" FormId="564" FormTitle="HRQoL-skjema" StudyName="ROAS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="291" FormId="565" FormTitle="Cushings syndrom" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="292" FormId="566" FormTitle="LCP Revurdering" StudyName="GBD" ParentId="528" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="294" FormId="567" FormTitle="Glasgow Benefit Inventory - Day 365" StudyName="BAR" ParentId="525" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="295" FormId="568" FormTitle="CT Day 90" StudyName="BAR" ParentId="525" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="297" FormId="570" FormTitle="Akromegali" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="298" FormId="571" FormTitle="Hyperprolaktinemi" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="300" FormId="572" FormTitle="Primær hyperparatyreoidisme" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="301" FormId="565" FormTitle="Cushings syndrom" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="303" FormId="573" FormTitle="Incidentalom" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-22T12:27:22.677Z"/>
	<Row StudyFormId="304" FormId="573" FormTitle="Incidentalom" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-22T12:27:22.677Z"/>
	<Row StudyFormId="305" FormId="471" FormTitle="Endotumor grunnskjema" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="306" FormId="574" FormTitle="Hypofysesvikt" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="307" FormId="575" FormTitle="Multippel Endokrin Neoplasi (MEN)" StudyName="ENDO.TUMOR" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="308" FormId="575" FormTitle="Multippel Endokrin Neoplasi (MEN)" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="310" FormId="577" FormTitle="Feokromocytom" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="312" FormId="578" FormTitle="Primær hyperaldosteronisme" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="313" FormId="579" FormTitle="Inklusjon - Beintetthet" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="316" FormId="580" FormTitle="Søvnregistrering" StudyName="FETTVEST" ParentId="606" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="317" FormId="581" FormTitle="Inklusjon - Kliniske parametre" StudyName="FETTVEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="318" FormId="582" FormTitle="Operasjonsdato - Kliniske parametre" StudyName="FETTVEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="319" FormId="583" FormTitle="3 mnd postoperativt - Kliniske parametre" StudyName="FETTVEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="320" FormId="584" FormTitle="12 mnd postoperativt - Kliniske parametre" StudyName="FETTVEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="321" FormId="585" FormTitle="24 mnd postoperativt - Kliniske parametre" StudyName="FETTVEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="322" FormId="586" FormTitle="60 mnd postoperativt - Kliniske parametre" StudyName="FETTVEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="323" FormId="587" FormTitle="12m postop -  Beintetthet" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="324" FormId="588" FormTitle="24m postop - Beintetthet" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="325" FormId="589" FormTitle="60m postop - Beintetthet" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="326" FormId="590" FormTitle="Inklusjon - IWQOL-Lite" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="327" FormId="591" FormTitle="3m postop - IWQOL-Lite" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="328" FormId="592" FormTitle="12m postop - IWQOL-Lite" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="329" FormId="593" FormTitle="24m postop - IWQOL-Lite" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="330" FormId="594" FormTitle="60m postop - IWQOL-Lite" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="331" FormId="595" FormTitle="Inklusjon - NUGG" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="332" FormId="463" FormTitle="Addisons sykdom" StudyName="ROAS" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="333" FormId="599" FormTitle="Infodoc" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="334" FormId="596" FormTitle="Basisregistrering" StudyName="SOREG" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="335" FormId="597" FormTitle="Operasjon" StudyName="SOREG" ParentId="596" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="336" FormId="598" FormTitle="Efter 1 år" StudyName="SOREG" ParentId="602" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="337" FormId="600" FormTitle="Efter 2 år" StudyName="SOREG" ParentId="598" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="338" FormId="601" FormTitle="Efter 5 år" StudyName="SOREG" ParentId="600" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="339" FormId="602" FormTitle="Postoperativt" StudyName="SOREG" ParentId="597" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="340" FormId="604" FormTitle="Operasjon (primær)" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="341" FormId="605" FormTitle="Utreise" StudyName="FETTVEST" ParentId="604" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="342" FormId="606" FormTitle="Inklusjon" StudyName="FETTVEST" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="343" FormId="607" FormTitle="Inklusjon" StudyName="FETTVEST" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="345" FormId="608" FormTitle="Inklusjon - SF-36" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="346" FormId="609" FormTitle="Test HbA1c formel for måloppnåelse" StudyName="TEST" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="347" FormId="610" FormTitle="Forslag til nye variable om nyresvikt" StudyName="TEST" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="348" FormId="611" FormTitle="Grunnskjema - Poliklinikk for Overvekt" StudyName="OVERVEKT" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="349" FormId="388" FormTitle="EKG beskrivelse" StudyName="OVERVEKT" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="350" FormId="612" FormTitle="Glukosemåling 24 timer" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="351" FormId="613" FormTitle="Inklusjon - Lungefunksjon" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="352" FormId="576" FormTitle="Vaksine" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="353" FormId="615" FormTitle="Inklusjon" StudyName="FETTVEST" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="354" FormId="616" FormTitle="Inklusjon - Utvidet SF-36" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="355" FormId="617" FormTitle="Utreise" StudyName="FETTVEST" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="356" FormId="618" FormTitle="Poliklinisk kontroll diabetes" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="357" FormId="619" FormTitle="APS-1" StudyName="ROAS" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="358" FormId="619" FormTitle="APS-1" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="359" FormId="620" FormTitle="Utreise" StudyName="FETTVEST" ParentId="604" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="361" FormId="621" FormTitle="Inklusjon - Epworth Sleepiness Scale" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="366" FormId="624" FormTitle="Matvaner" StudyName="FETTVEST" ParentId="606" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="367" FormId="627" FormTitle="3m postop - Utvidet SF-36" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="368" FormId="628" FormTitle="Inklusjon - Roma II kort" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="369" FormId="539" FormTitle="IWQoL-Lite" StudyName="OVERVEKT" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="372" FormId="404" FormTitle="Epworth Sleepiness Scale" StudyName="OVERVEKT" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="374" FormId="629" FormTitle="Pasientskjema - Overvekt" StudyName="OVERVEKT" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="375" FormId="490" FormTitle="SF-36 Resultat" StudyName="OVERVEKT" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="377" FormId="631" FormTitle="Dupuytren Preoperativ vurdering" StudyName="HAND" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="378" FormId="632" FormTitle="Fleksjon/Ekstensjon Venstre" StudyName="HAND" ParentId="631" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="379" FormId="630" FormTitle="Dupuytren behandling" StudyName="HAND" ParentId="631" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="380" FormId="633" FormTitle="Bevegelighet - Hånd og arm" StudyName="HAND" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="381" FormId="634" FormTitle="Monofilament" StudyName="HAND" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="383" FormId="635" FormTitle="Kraft" StudyName="HAND" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="385" FormId="636" FormTitle="Smerter" StudyName="HAND" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="387" FormId="638" FormTitle="CTS Etterkontroll 4 uker" StudyName="HAND" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="388" FormId="637" FormTitle="Fysio-/ergoterapi" StudyName="HAND" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="389" FormId="471" FormTitle="Endotumor grunnskjema" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="390" FormId="571" FormTitle="Hyperprolaktinemi" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="391" FormId="574" FormTitle="Hypofysesvikt" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="392" FormId="577" FormTitle="Feokromocytom" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="393" FormId="578" FormTitle="Primær hyperaldosteronisme" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="394" FormId="572" FormTitle="Primær hyperparatyreoidisme" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="395" FormId="570" FormTitle="Akromegali" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="396" FormId="640" FormTitle="Osteoporose" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="397" FormId="599" FormTitle="Infodoc" StudyName="JSP" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="398" FormId="324" FormTitle="Kurvenotat" StudyName="JSP" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="399" FormId="142" FormTitle="Hulten pleietyngde" StudyName="JSP" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="400" FormId="317" FormTitle="Administrasjon" StudyName="JSP" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="401" FormId="271" FormTitle="Notat, lege" StudyName="JSP" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="402" FormId="331" FormTitle="Anamnese" StudyName="JSP" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="403" FormId="332" FormTitle="Sosial anamnese" StudyName="JSP" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="404" FormId="329" FormTitle="Enkelt legenotat" StudyName="JSP" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="405" FormId="641" FormTitle="Fleksjon/Ekstensjon Høyre" StudyName="HAND" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="406" FormId="642" FormTitle="Tyreoideasykdom" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="407" FormId="643" FormTitle="Bakgrunn - Endokrin tumor" StudyName="ENDO.TUMOR" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="408" FormId="643" FormTitle="Bakgrunn - Endokrin tumor" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="409" FormId="643" FormTitle="Bakgrunn - Endokrin tumor" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="411" FormId="644" FormTitle="Primær binyrebarksvikt (Addisons sykdom)" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="412" FormId="532" FormTitle="Thyroideasykdom" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="416" FormId="645" FormTitle="Medfødt binyrebarkhyperplasi (CAH)" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="417" FormId="647" FormTitle="Slag Akuttskjema v3.0" StudyName="SLAG" ParentId="660" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="418" FormId="644" FormTitle="Primær binyrebarksvikt (Addisons sykdom)" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="419" FormId="644" FormTitle="Primær binyrebarksvikt (Addisons sykdom)" StudyName="ROAS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="421" FormId="535" FormTitle="Endokrinologisk forskningsbiobank" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="422" FormId="649" FormTitle="Grunndata diabetes" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="423" FormId="649" FormTitle="Grunndata diabetes" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="424" FormId="575" FormTitle="Multippel Endokrin Neoplasi (MEN)" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="425" FormId="650" FormTitle="12m postop - Roma II kort" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="426" FormId="651" FormTitle="60m postop - Roma II kort" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="427" FormId="652" FormTitle="3m postoperativt" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="428" FormId="640" FormTitle="Osteoporose" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="429" FormId="655" FormTitle="First Admission" StudyName="BAR" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="430" FormId="656" FormTitle="New Admission" StudyName="BAR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="431" FormId="657" FormTitle="Death" StudyName="BAR" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="432" FormId="658" FormTitle="Unscheduled follow-up" StudyName="BAR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="433" FormId="542" FormTitle="Fysioterapinotat" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="434" FormId="659" FormTitle="Eliminasjon og dusj" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="435" FormId="660" FormTitle="Utskrivning" StudyName="SLAG" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="436" FormId="661" FormTitle="Status i akuttfasen" StudyName="SLAG" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="437" FormId="662" FormTitle="Kriterier for slagdiagnosen" StudyName="SLAG" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="438" FormId="663" FormTitle="Behandlingskjeden" StudyName="SLAG" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="439" FormId="664" FormTitle="Akuttbehandling" StudyName="SLAG" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="440" FormId="665" FormTitle="Slag Oppfølging 3 mnd v3.0" StudyName="SLAG" ParentId="647" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="441" FormId="666" FormTitle="Innkomstnotat hoftebrudd" StudyName="HOFTE" Repeatable="1" SurveyStatus="Open" HideComment="2" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="442" FormId="667" FormTitle="Hoftebruddregister" StudyName="HOFTE" Repeatable="1" SurveyStatus="Closed" HideComment="2" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="443" FormId="668" FormTitle="Discharge (New Admission)" StudyName="BAR" ParentId="656" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="444" FormId="669" FormTitle="Faste medisiner - før debut av hjerneslaget" StudyName="SLAG" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="445" FormId="670" FormTitle="Supplerende undersøkelser" StudyName="SLAG" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="446" FormId="671" FormTitle="Risikofaktorer før hjerneslaget" StudyName="SLAG" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="448" FormId="672" FormTitle="Generell endokrinologi" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="449" FormId="672" FormTitle="Generell endokrinologi" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="450" FormId="673" FormTitle="Periodisk stell" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="451" FormId="653" FormTitle="Tilstand før det aktuelle hjerneslaget" StudyName="SLAG" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="453" FormId="674" FormTitle="Faste medisiner - ved utskriving" StudyName="SLAG" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="454" FormId="648" FormTitle="Legemiddelgjennomgang" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T13:12:14.463Z"/>
	<Row StudyFormId="455" FormId="675" FormTitle="Hypofysemøte" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="456" FormId="676" FormTitle="Binyremøte" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="457" FormId="678" FormTitle="Gamma-nagling" StudyName="HOFTE" Repeatable="1" SurveyStatus="Open" HideComment="2" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="458" FormId="680" FormTitle="Insulinpumpe - Intervalldosering" StudyName="TEST" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="459" FormId="681" FormTitle="12m postop - Utvidet SF-36" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="460" FormId="682" FormTitle="12m postop - NUGG" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="461" FormId="683" FormTitle="24m postop - Utvidet SF-36" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="462" FormId="684" FormTitle="60m postop - Utvidet SF-36" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="467" FormId="626" FormTitle="Forslag til avslutning NDV" StudyName="TEST" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="468" FormId="685" FormTitle="Test av NDV Amputasjonsvariable" StudyName="TEST" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="469" FormId="175" FormTitle="CAM - delirvurdering " StudyName="HOFTE" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="470" FormId="688" FormTitle="Antibiotika" StudyName="HOFTE" Repeatable="1" SurveyStatus="Closed" HideComment="2" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="471" FormId="689" FormTitle="Hemiprotese primært" StudyName="HOFTE" Repeatable="1" SurveyStatus="Open" HideComment="2" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="472" FormId="690" FormTitle="Avvik" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="473" FormId="425" FormTitle="Labrekvisisjon" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="474" FormId="692" FormTitle="Autoimmunt polyendokrint syndrom type 1 (APS-1)" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="476" FormId="693" FormTitle="Behandlende lege" StudyName="ROAS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="477" FormId="694" FormTitle="Be om opplysninger" StudyName="ROAS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="482" FormId="697" FormTitle="Endokrine tumorsyndromer (MEN)" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="483" FormId="698" FormTitle="Richard Hip Pins" StudyName="HOFTE" Repeatable="1" SurveyStatus="Open" HideComment="2" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="485" FormId="692" FormTitle="Autoimmunt polyendokrint syndrom type 1 (APS-1)" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="486" FormId="699" FormTitle="Hypoparatyreoidisme" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="487" FormId="699" FormTitle="Hypoparatyreoidisme" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="488" FormId="699" FormTitle="Hypoparatyreoidisme" StudyName="ROAS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="489" FormId="692" FormTitle="Autoimmunt polyendokrint syndrom type 1 (APS-1)" StudyName="ROAS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="490" FormId="702" FormTitle="Ikke møtt til time" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="491" FormId="645" FormTitle="Medfødt binyrebarkhyperplasi (CAH)" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="493" FormId="703" FormTitle="General Assessment" StudyName="NAPOS" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="494" FormId="379" FormTitle="Cornell depresjonskala" StudyName="HOFTE" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="495" FormId="705" FormTitle="Slag Akuttskjema v3.0a" StudyName="SLAG" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="496" FormId="706" FormTitle="Slag Oppfølging 3 mnd v3.0a" StudyName="SLAG" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="497" FormId="709" FormTitle="12 mnd postoperativt" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="498" FormId="710" FormTitle="EQ-5D (test)" StudyName="HOFTE" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="499" FormId="711" FormTitle="Behandling utenfor protokoll" StudyName="VREX" ParentId="757" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="500" FormId="712" FormTitle="Inklu - Audiometri" StudyName="VREX" ParentId="757" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="501" FormId="713" FormTitle="Inklu - PANQOL - Quality of Life" StudyName="VREX" ParentId="757" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="503" FormId="715" FormTitle="Utskriving" StudyName="HOFTE" Repeatable="1" SurveyStatus="Closed" HideComment="2" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="504" FormId="255" FormTitle="Øyestatus" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="505" FormId="256" FormTitle="Opplæring diabetes" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="506" FormId="298" FormTitle="PAID - Problemområder i Diabetes" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="507" FormId="305" FormTitle="Svangerskapskontroll" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="508" FormId="310" FormTitle="Telefonisk kontakt" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="509" FormId="404" FormTitle="Epworth Sleepiness Scale" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="510" FormId="534" FormTitle="Insulinbehandling" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="511" FormId="618" FormTitle="Poliklinisk kontroll diabetes" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="512" FormId="702" FormTitle="Ikke møtt til time" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="513" FormId="252" FormTitle="Poliklinisk kontroll" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="514" FormId="254" FormTitle="Fotstatus" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="515" FormId="257" FormTitle="Laboratoriedata" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="516" FormId="258" FormTitle="NDV Årsrapport" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="517" FormId="289" FormTitle="Insulindosering" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="518" FormId="295" FormTitle="Insulinpumpe" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="519" FormId="299" FormTitle="Grunndata" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="520" FormId="302" FormTitle="Komplikasjoner" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="521" FormId="303" FormTitle="Behandlingsmål" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="522" FormId="304" FormTitle="Blodtrykk 24-timer" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="523" FormId="309" FormTitle="Årskontroll" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="524" FormId="314" FormTitle="Insulindosering" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="525" FormId="318" FormTitle="Poliklinisk kontroll" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="526" FormId="319" FormTitle="Insulindosering" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="527" FormId="320" FormTitle="Årskontroll" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="528" FormId="321" FormTitle="Poliklinisk kontroll" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="529" FormId="361" FormTitle="Poliklinisk kontroll" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="530" FormId="363" FormTitle="Årskontroll" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="531" FormId="387" FormTitle="Fotstatus" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="532" FormId="392" FormTitle="Primærhelsetjeneste" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="533" FormId="393" FormTitle="Årskontroll" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="534" FormId="406" FormTitle="Insulindosering" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="535" FormId="409" FormTitle="Årskontroll" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="536" FormId="483" FormTitle="Poliklinisk kontroll" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="537" FormId="498" FormTitle="Startskjema" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="538" FormId="499" FormTitle="Oppfølging" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="539" FormId="520" FormTitle="Fotstatus" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="540" FormId="716" FormTitle="HypOtyreose" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="541" FormId="717" FormTitle="HypERtyreose" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="542" FormId="718" FormTitle="Tyreoideasykdom uten funksjonsforstyrrelse" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="549" FormId="719" FormTitle="Test av constraints og skjulte sider" StudyName="TEST" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="550" FormId="675" FormTitle="Hypofysemøte" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="551" FormId="676" FormTitle="Binyremøte" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="553" FormId="721" FormTitle="Hypofysemøte" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="555" FormId="722" FormTitle="Binyremøte" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="556" FormId="723" FormTitle="Glideskrue med plate" StudyName="HOFTE" Repeatable="1" SurveyStatus="Open" HideComment="2" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="557" FormId="722" FormTitle="Binyremøte" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="558" FormId="720" FormTitle="Insulinpumpe - Standarddosering" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="559" FormId="724" FormTitle="Insulinpumpe - Alternativ dosering" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="560" FormId="721" FormTitle="Hypofysemøte" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="561" FormId="708" FormTitle="Prekontroll" StudyName="VOSSBAR" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="562" FormId="725" FormTitle="Fotstatus" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="563" FormId="725" FormTitle="Fotstatus" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="564" FormId="727" FormTitle="Radiologihenvisning DSH" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="565" FormId="728" FormTitle="Status presens (test)" StudyName="MEDISIN" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="566" FormId="479" FormTitle="Anamnese (test)" StudyName="MEDISIN" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="567" FormId="479" FormTitle="Anamnese (test)" StudyName="HOFTE" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="569" FormId="728" FormTitle="Status presens (test)" StudyName="HOFTE" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="570" FormId="686" FormTitle="Innkomstjournal diabetes" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="571" FormId="687" FormTitle="Epikrise" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="572" FormId="729" FormTitle="Hoftebruddregister" StudyName="HOFTE" Repeatable="1" SurveyStatus="Closed" HideComment="2" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="573" FormId="730" FormTitle="Antibiotika (test)" StudyName="HOFTE" Repeatable="1" SurveyStatus="Closed" HideComment="2" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="574" FormId="533" FormTitle="Hypoparatyreoidisme" StudyName="ROAS" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="580" FormId="733" FormTitle="Årskontroll diabetes (full)" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="582" FormId="734" FormTitle="Epikrise diabetes" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="584" FormId="536" FormTitle="Primær hypogonadisme" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="586" FormId="733" FormTitle="Årskontroll diabetes (full)" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="587" FormId="734" FormTitle="Epikrise diabetes" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="588" FormId="686" FormTitle="Innkomstjournal diabetes" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="589" FormId="738" FormTitle="Kontroll 3 mnd - Bariatri" StudyName="VOSSBAR" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="590" FormId="739" FormTitle="Kontroll 6 mnd - Bariatri" StudyName="VOSSBAR" ParentId="708" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="591" FormId="733" FormTitle="Årskontroll diabetes (full)" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="592" FormId="740" FormTitle="Kontroll 12 mnd - Bariatri" StudyName="VOSSBAR" ParentId="708" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="593" FormId="741" FormTitle="Kontroll 18 mnd - Bariatri" StudyName="VOSSBAR" ParentId="708" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="594" FormId="742" FormTitle="Kontroll 24 mnd - Bariatri" StudyName="VOSSBAR" ParentId="708" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="595" FormId="743" FormTitle="Årskontroll diabetes (som tillegg)" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="596" FormId="743" FormTitle="Årskontroll diabetes (som tillegg)" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="599" FormId="468" FormTitle="Årskontroll diabetes" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="601" FormId="490" FormTitle="SF-36 Resultat" StudyName="ASTOR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="602" FormId="494" FormTitle="Demografi" StudyName="ASTOR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="603" FormId="693" FormTitle="Behandlende lege" StudyName="ASTOR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="604" FormId="699" FormTitle="Hypoparatyreoidisme" StudyName="ASTOR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="605" FormId="704" FormTitle="Hypopara medikamenter" StudyName="ASTOR" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="606" FormId="737" FormTitle="Labprøver" StudyName="ASTOR" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="607" FormId="744" FormTitle="Koblingsdata Hypopara-prosjekt" StudyName="ASTOR" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="608" FormId="726" FormTitle="Anamnese 0 mnd" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="609" FormId="735" FormTitle="Klinisk undersøkelse 0 mnd" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="610" FormId="745" FormTitle="Kontroll 9 mnd - Bariatri" StudyName="VOSSBAR" ParentId="708" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="611" FormId="746" FormTitle="Kontroll 5 år - Bariatri" StudyName="VOSSBAR" ParentId="708" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="612" FormId="747" FormTitle="Kontroll 10 år - Bariatri" StudyName="VOSSBAR" ParentId="708" Repeatable="0" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="613" FormId="691" FormTitle="Postoperative registreringer" StudyName="VOSSBAR" ParentId="708" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="614" FormId="679" FormTitle="Preoperative registreringer" StudyName="VOSSBAR" ParentId="708" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="615" FormId="652" FormTitle="3m postoperativt" StudyName="VOSSBAR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="616" FormId="748" FormTitle="POSSUM" StudyName="VOSSBAR" ParentId="708" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="617" FormId="616" FormTitle="Inklusjon - Utvidet SF-36" StudyName="VOSSBAR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="618" FormId="628" FormTitle="Inklusjon - Roma II kort" StudyName="VOSSBAR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="619" FormId="590" FormTitle="Inklusjon - IWQOL-Lite" StudyName="VOSSBAR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="620" FormId="591" FormTitle="3m postop - IWQOL-Lite" StudyName="VOSSBAR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="621" FormId="627" FormTitle="3m postop - Utvidet SF-36" StudyName="VOSSBAR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="622" FormId="650" FormTitle="12m postop - Roma II kort" StudyName="VOSSBAR" ParentId="708" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="623" FormId="681" FormTitle="12m postop - Utvidet SF-36" StudyName="VOSSBAR" ParentId="708" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="624" FormId="593" FormTitle="24m postop - IWQOL-Lite" StudyName="VOSSBAR" ParentId="708" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="625" FormId="683" FormTitle="24m postop - Utvidet SF-36" StudyName="VOSSBAR" ParentId="708" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="626" FormId="684" FormTitle="60m postop - Utvidet SF-36" StudyName="VOSSBAR" ParentId="708" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="627" FormId="651" FormTitle="60m postop - Roma II kort" StudyName="VOSSBAR" ParentId="708" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="628" FormId="594" FormTitle="60m postop - IWQOL-Lite" StudyName="VOSSBAR" ParentId="708" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="630" FormId="592" FormTitle="12m postop - IWQOL-Lite" StudyName="VOSSBAR" ParentId="708" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="633" FormId="749" FormTitle="3m postop - Roma II kort" StudyName="VOSSBAR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="634" FormId="686" FormTitle="Innkomstjournal diabetes" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="635" FormId="734" FormTitle="Epikrise diabetes" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="636" FormId="751" FormTitle="Preoperative registreringer" StudyName="VOSSBAR" ParentId="708" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="637" FormId="752" FormTitle="Postoperative registreringer" StudyName="VOSSBAR" ParentId="708" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="638" FormId="753" FormTitle="24m postop - Roma II kort" StudyName="VOSSBAR" ParentId="708" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="639" FormId="536" FormTitle="Primær hypogonadisme" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="640" FormId="736" FormTitle="Opplæring insulinpumpe" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="641" FormId="736" FormTitle="Opplæring insulinpumpe" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="644" FormId="756" FormTitle="Inklu - EQ-5D-3L" StudyName="VREX" ParentId="757" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="645" FormId="760" FormTitle="Fallrisiko - Stratify" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="646" FormId="761" FormTitle="Radiological follow-up" StudyName="BAR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="647" FormId="763" FormTitle="First contact" StudyName="BAR" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="648" FormId="764" FormTitle="MODY Prøvesvar" StudyName="MODY" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="649" FormId="606" FormTitle="Inklusjon" StudyName="VOSSBAR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="652" FormId="709" FormTitle="12 mnd postoperativt" StudyName="VOSSBAR" ParentId="606" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="653" FormId="766" FormTitle="Day 7 or departure (new admission)" StudyName="BAR" ParentId="656" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="654" FormId="754" FormTitle="MOBID-2 Smerteskala" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="656" FormId="757" FormTitle="Inklu - Registreringsskjema - Lege" StudyName="VREX" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="657" FormId="771" FormTitle="1 år - PANQOL - Quality of Life" StudyName="VREX" ParentId="775" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="658" FormId="772" FormTitle="2 år - PANQOL - Quality of Life" StudyName="VREX" ParentId="776" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="659" FormId="773" FormTitle="3 år - PANQOL - Quality of Life" StudyName="VREX" ParentId="777" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="660" FormId="774" FormTitle="4 år - PANQOL - Quality of Life" StudyName="VREX" ParentId="778" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="661" FormId="775" FormTitle="1 år - Registreringsskjema - Lege" StudyName="VREX" ParentId="757" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="662" FormId="776" FormTitle="2 år - Registreringsskjema - Lege" StudyName="VREX" ParentId="775" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="663" FormId="777" FormTitle="3 år - Registreringsskjema - Lege" StudyName="VREX" ParentId="776" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="664" FormId="778" FormTitle="4 år - Registreringsskjema - Lege" StudyName="VREX" ParentId="777" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="665" FormId="779" FormTitle="1 år - EQ-5D-3L" StudyName="VREX" ParentId="775" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="666" FormId="780" FormTitle="2 år - EQ-5D-3L" StudyName="VREX" ParentId="776" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="667" FormId="781" FormTitle="3 år - EQ-5D-3L" StudyName="VREX" ParentId="777" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="668" FormId="782" FormTitle="4 år - EQ-5D-3L" StudyName="VREX" ParentId="778" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="669" FormId="768" FormTitle="1 år - Økonomi" StudyName="VREX" ParentId="775" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="670" FormId="784" FormTitle="1 år - Audiometri" StudyName="VREX" ParentId="775" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="671" FormId="785" FormTitle="2 år - Audiometri" StudyName="VREX" ParentId="776" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="672" FormId="786" FormTitle="3 år - Audiometri" StudyName="VREX" ParentId="777" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="673" FormId="787" FormTitle="4 år - Audiometri" StudyName="VREX" ParentId="778" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="674" FormId="769" FormTitle="Nattrapport" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="675" FormId="788" FormTitle="Avvik" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="676" FormId="791" FormTitle="Svangerskapskontroll diabetes" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="677" FormId="791" FormTitle="Svangerskapskontroll diabetes" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="679" FormId="789" FormTitle="Kvalitetsregister, fysioterapi" StudyName="BALANSE" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="680" FormId="790" FormTitle="Balansestudie, lege" StudyName="BALANSE" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="682" FormId="792" FormTitle="Smerteskjema" StudyName="BALANSE" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="683" FormId="793" FormTitle="Svimmelhet" StudyName="BALANSE" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="684" FormId="707" FormTitle="SF - 36" StudyName="BALANSE" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="685" FormId="794" FormTitle="Vanskeligheter pga. svimmelhet" StudyName="BALANSE" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="687" FormId="798" FormTitle="Inklu - Økonomi" StudyName="VREX" ParentId="757" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="688" FormId="799" FormTitle="Utskriving" StudyName="HOFTE" Repeatable="1" SurveyStatus="Open" HideComment="2" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="689" FormId="795" FormTitle="Kontroll 6 mnd" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="690" FormId="765" FormTitle="Kontroll lege 12 mnd (1 år)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="693" FormId="801" FormTitle="24 mnd postoperativt" StudyName="FETTVEST" ParentId="606" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="694" FormId="801" FormTitle="24 mnd postoperativt" StudyName="VOSSBAR" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="695" FormId="720" FormTitle="Insulinpumpe - Standarddosering" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="696" FormId="724" FormTitle="Insulinpumpe - Alternativ dosering" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="697" FormId="805" FormTitle="Inklu - Kalorisk prøve" StudyName="VREX" ParentId="757" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="698" FormId="806" FormTitle="1 år - Kalorisk prøve" StudyName="VREX" ParentId="775" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="699" FormId="807" FormTitle="2 år - Kalorisk prøve" StudyName="VREX" ParentId="776" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="700" FormId="808" FormTitle="3 år - Kalorisk prøve" StudyName="VREX" ParentId="777" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="701" FormId="809" FormTitle="4 år - Kalorisk prøve" StudyName="VREX" ParentId="778" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="702" FormId="810" FormTitle="Mobilt røntgen DSH" StudyName="GBD" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="703" FormId="811" FormTitle="Hoftebruddregister" StudyName="HOFTE" Repeatable="1" SurveyStatus="Closed" HideComment="2" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="704" FormId="812" FormTitle="Hypofysemøte" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="705" FormId="812" FormTitle="Hypofysemøte" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="706" FormId="813" FormTitle="Basisregistrering sykepleier" StudyName="OVERVEKT" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="707" FormId="814" FormTitle="Basisregistrering kirurg" StudyName="OVERVEKT" ParentId="813" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="708" FormId="815" FormTitle="Grunnskjema - Poliklinikk for overvekt" StudyName="OVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="709" FormId="816" FormTitle="Basisregistrering labdata" StudyName="OVERVEKT" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="710" FormId="817" FormTitle="Basisregistrering minus PFO grunnskjema" StudyName="OVERVEKT" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="711" FormId="783" FormTitle="Inklu - Balansetest" StudyName="VREX" ParentId="757" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="712" FormId="819" FormTitle="Svangerskapskonsultasjon diabetes" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="713" FormId="819" FormTitle="Svangerskapskonsultasjon diabetes" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="714" FormId="818" FormTitle="Opplevelse av svimmelhet" StudyName="BALANSE" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="715" FormId="820" FormTitle="Bakgrunn - Autoimmunitet" StudyName="ROAS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="716" FormId="820" FormTitle="Bakgrunn - Autoimmunitet" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="717" FormId="821" FormTitle="Bakgrunn - Endokrin tumor" StudyName="ENDO.TUMOR" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="718" FormId="821" FormTitle="Bakgrunn - Endokrin tumor" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="719" FormId="821" FormTitle="Bakgrunn - Endokrin tumor" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="723" FormId="823" FormTitle="Binyretumor" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="724" FormId="823" FormTitle="Binyretumor" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="727" FormId="822" FormTitle="Hypofysetumor" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="728" FormId="822" FormTitle="Hypofysetumor" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="729" FormId="824" FormTitle="Avvik" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="733" FormId="697" FormTitle="Endokrine tumorsyndromer (MEN)" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="734" FormId="826" FormTitle="Kontroll lege 24 mnd (2 år)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="735" FormId="827" FormTitle="Mellomkontroll  3 mnd" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="736" FormId="828" FormTitle="Første legesamtale" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="737" FormId="829" FormTitle="Mellomkontroll  6 mnd" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="738" FormId="830" FormTitle="Mellomkontroll  9 mnd" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="739" FormId="831" FormTitle="Mellomkontroll 15 mnd (1 år 3 mnd)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="740" FormId="832" FormTitle="Mellomkontroll 18 mnd (1 år 6 mnd)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="741" FormId="833" FormTitle="Mellomkontroll 21 mnd (1 år 9 mnd)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="742" FormId="834" FormTitle="Mellomkontroll 27 mnd (2 år 3 mnd)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="743" FormId="835" FormTitle="Mellomkontroll 30 mnd (2 år 6 mnd)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="744" FormId="836" FormTitle="Primær hypERtyreose" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="745" FormId="837" FormTitle="Primær hypOtyreose" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="746" FormId="838" FormTitle="Tyreoideasykdom uten funksjonsforstyrrelse" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="747" FormId="466" FormTitle="CTS Preop vurdering" StudyName="CTS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="748" FormId="475" FormTitle="CTS Operasjon" StudyName="CTS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="749" FormId="467" FormTitle="Kvikk-DASH, CTS Preop" StudyName="CTS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="750" FormId="638" FormTitle="CTS Etterkontroll 4 uker" StudyName="CTS" ParentId="475" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="751" FormId="839" FormTitle="Mellomkontroll 33 mnd (2 år 9 mnd)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="752" FormId="840" FormTitle="Kontroll lege 36 mnd (3 år)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="753" FormId="825" FormTitle="Avsluttet oppfølging" StudyName="BARNEOVERVEKT" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="754" FormId="841" FormTitle="CTS Preop pasientskjema" StudyName="HAND" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="755" FormId="841" FormTitle="CTS Preop pasientskjema" StudyName="CTS" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="756" FormId="842" FormTitle="Kvikk-DASH, CTS Postop 6mnd" StudyName="HAND" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="757" FormId="842" FormTitle="Kvikk-DASH, CTS Postop 6mnd" StudyName="CTS" ParentId="475" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="758" FormId="843" FormTitle="Vaksine" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="759" FormId="844" FormTitle="Infeksjonsregistrering" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="760" FormId="845" FormTitle="Helseopplysninger" StudyName="AlfaHelse" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="761" FormId="244" FormTitle="IPAQ" StudyName="AlfaHelse" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="763" FormId="846" FormTitle="Kostvaner" StudyName="AlfaHelse" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="764" FormId="847" FormTitle="Arbeidsmiljø" StudyName="AlfaHelse" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="765" FormId="474" FormTitle="Kostregistrering 2 dager" StudyName="GBD.KOST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="766" FormId="401" FormTitle="MNA - Mini Nutritional Assessment" StudyName="GBD.KOST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="767" FormId="402" FormTitle="Kostregistrering ved innkomst" StudyName="GBD.KOST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="768" FormId="403" FormTitle="MUST - Underernæring" StudyName="GBD.KOST" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="769" FormId="457" FormTitle="MDS 3.0 Section K - Swallowing and Nutritional Status" StudyName="GBD.KOST" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="770" FormId="360" FormTitle="Sonder og katetre" StudyName="GBD.KOST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="771" FormId="848" FormTitle="Fallforebygging - tiltaksplan" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="772" FormId="850" FormTitle="Ernæringsplan" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="773" FormId="850" FormTitle="Ernæringsplan" StudyName="GBD.KOST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="774" FormId="622" FormTitle="CAS - Clinical Activity Score" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="775" FormId="851" FormTitle="Cushings syndrom" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="776" FormId="851" FormTitle="Cushings syndrom" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="777" FormId="852" FormTitle="Kostsamtale ved innkomst" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="778" FormId="852" FormTitle="Kostsamtale ved innkomst" StudyName="GBD.KOST" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="779" FormId="853" FormTitle="Mellomkontroll 39 mnd (3 år 3 mnd)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="780" FormId="854" FormTitle="Mellomkontroll 42 mnd (3 år 6 mnd)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="781" FormId="855" FormTitle="Mellomkontroll 45 mnd (3 år 9 mnd)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="782" FormId="856" FormTitle="Kontroll lege 48 mnd (4 år)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="783" FormId="857" FormTitle="Mellomkontroll 51 mnd (4 år 3 mnd)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="784" FormId="858" FormTitle="Mellomkontroll 54 mnd (4 år 6 mnd)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="785" FormId="859" FormTitle="Mellomkontroll 57 mnd (4 år 9 mnd)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="786" FormId="860" FormTitle="Kontroll lege 60 mnd (5 år)" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="787" FormId="861" FormTitle="Postnotat diabetes" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="788" FormId="861" FormTitle="Postnotat diabetes" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="789" FormId="862" FormTitle="Kartlegging" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="790" FormId="863" FormTitle="Første legesamtale" StudyName="BARNEOVERVEKT" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="793" FormId="864" FormTitle="Administrasjon" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="795" FormId="865" FormTitle="1 år - Balansetest" StudyName="VREX" ParentId="775" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="796" FormId="866" FormTitle="2 år - Balansetest" StudyName="VREX" ParentId="776" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="797" FormId="867" FormTitle="3 år - Balansetest" StudyName="VREX" ParentId="777" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="798" FormId="868" FormTitle="4 år - Balansetest" StudyName="VREX" ParentId="778" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="799" FormId="869" FormTitle="2 år - Økonomi" StudyName="VREX" ParentId="776" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="800" FormId="870" FormTitle="3 år - Økonomi" StudyName="VREX" ParentId="777" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="801" FormId="871" FormTitle="4 år - Økonomi" StudyName="VREX" ParentId="778" Repeatable="0" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="806" FormId="873" FormTitle="CGM - Kontinuerlig glukosemonitorering" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="813" FormId="623" FormTitle="Samtykke Norsk Diabetesregister for Voksne" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="815" FormId="623" FormTitle="Samtykke Norsk Diabetesregister for Voksne" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="816" FormId="874" FormTitle="CGM - Evaluering etter 6 mnd" StudyName="NDV" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="817" FormId="873" FormTitle="CGM - Kontinuerlig glukosemonitorering" StudyName="ENDO" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="818" FormId="874" FormTitle="CGM - Evaluering etter 6 mnd" StudyName="ENDO" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="819" FormId="820" FormTitle="Bakgrunn - Autoimmunitet" StudyName="NDV" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="820" FormId="164" FormTitle="MADRS" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="821" FormId="435" FormTitle="MMSE-NR" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-12-01T14:16:29.073Z"/>
	<Row StudyFormId="822" FormId="343" FormTitle="NPI-Q Kortversjon" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="823" FormId="160" FormTitle="ESAS" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="824" FormId="175" FormTitle="CAM - delirvurdering " StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="825" FormId="262" FormTitle="GDS depresjonsskala" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="826" FormId="325" FormTitle="Barthel ADL-indeks" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="827" FormId="380" FormTitle="OBS Demens" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="828" FormId="401" FormTitle="MNA - Mini Nutritional Assessment" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="829" FormId="473" FormTitle="QUALID - Livskvalitet ved langtkommen demens" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="830" FormId="760" FormTitle="Fallrisiko - Stratify" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="831" FormId="754" FormTitle="MOBID-2 Smerteskala" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="832" FormId="484" FormTitle="Boston Questionnaire" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="833" FormId="298" FormTitle="PAID - Problemområder i Diabetes" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="834" FormId="404" FormTitle="Epworth Sleepiness Scale" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="836" FormId="875" FormTitle="Kvikk-DASH" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="839" FormId="876" FormTitle="Hoftebruddregister" StudyName="HOFTE" Repeatable="1" SurveyStatus="Open" HideComment="2" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="840" FormId="877" FormTitle="ESAS-r" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="841" FormId="877" FormTitle="ESAS-r" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="842" FormId="878" FormTitle="Legemiddelgjennomgang" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T13:12:19.470Z"/>
	<Row StudyFormId="844" FormId="879" FormTitle="PAM - Patient Activation Measure" StudyName="TEST" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="845" FormId="804" FormTitle="BARS - Brief Agitation Rating Scale" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="846" FormId="488" FormTitle="HAS-BLED  Blødningsrisiko" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="847" FormId="700" FormTitle="WEL-SF" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="848" FormId="522" FormTitle="Klinisk demensvurdering (KDV)" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T13:41:49.120Z"/>
	<Row StudyFormId="849" FormId="767" FormTitle="Neuropsychiatric Inventory (NPI)" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="850" FormId="431" FormTitle="Demens - MiniCog" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="851" FormId="485" FormTitle="Demens - Klokketest" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="852" FormId="457" FormTitle="MDS 3.0 Section K - Swallowing and Nutritional Status" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Closed" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="853" FormId="430" FormTitle="Demens - Belastningsskala pårørende" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Design" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="863" FormId="883" FormTitle="Sonder og katetre" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="0" LastUpdate="2016-04-20T13:12:49.530Z"/>
	<Row StudyFormId="864" FormId="885" FormTitle="Mobilt røntgen DSH" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="865" FormId="519" FormTitle="Pasientskjema - Synacthenstudien" StudyName="ENDO.TEST" Repeatable="1" SurveyStatus="Open" HideComment="0" LastUpdate="2016-06-06T13:46:59.887Z"/>
	<Row StudyFormId="866" FormId="886" FormTitle="Notat, pleie" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="2" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="867" FormId="804" FormTitle="BARS - Brief Agitation Rating Scale" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="0" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="868" FormId="755" FormTitle="Insulinfølsomhet" StudyName="TEST" Repeatable="1" SurveyStatus="Design" HideComment="0" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="870" FormId="603" FormTitle="Sykepleiesammenfatning" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="0" LastUpdate="2016-04-29T12:02:36.513Z"/>
	<Row StudyFormId="871" FormId="887" FormTitle="Livets siste dager - Oppstart" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-21T12:14:57.297Z"/>
	<Row StudyFormId="872" FormId="888" FormTitle="Livets siste dager - Fortløpende vurderinger" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-06-06T13:28:54.597Z"/>
	<Row StudyFormId="875" FormId="891" FormTitle="Oppfølgingssamtale" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-20T11:36:50.693Z"/>
	<Row StudyFormId="876" FormId="892" FormTitle="Livets siste dager - Revurdering" StudyName="GBD" ParentId="887" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-21T12:15:12.900Z"/>
	<Row StudyFormId="877" FormId="522" FormTitle="Klinisk demensvurdering (KDV)" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="0" LastUpdate="2016-04-20T13:41:49.120Z"/>
	<Row StudyFormId="878" FormId="889" FormTitle="Livets siste dager - Ved dødsfallet" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="0" LastUpdate="2016-04-21T12:14:31.080Z"/>
	<Row StudyFormId="879" FormId="511" FormTitle="Fysio-/ergoterapi oppstart av behandling" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="0" LastUpdate="2016-04-21T09:11:26.240Z"/>
	<Row StudyFormId="880" FormId="512" FormTitle="Fysio-/ergoterapi avslutning av behandling " StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="0" LastUpdate="2016-04-21T09:11:50.273Z"/>
	<Row StudyFormId="881" FormId="527" FormTitle="Innkomstsamtale (korttid)" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-21T10:51:29.407Z"/>
	<Row StudyFormId="882" FormId="551" FormTitle="Aktivitetsplan" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-04-21T10:48:32.667Z"/>
	<Row StudyFormId="883" FormId="559" FormTitle="Baseline visit" StudyName="EVOLVE" Repeatable="1" SurveyStatus="Design" HideComment="0" LastUpdate="2016-05-02T07:44:00.847Z"/>
	<Row StudyFormId="884" FormId="560" FormTitle="Familiemedlemmers vekt" StudyName="BARNEOVERVEKT" Repeatable="1" SurveyStatus="Design" HideComment="0" LastUpdate="2016-05-03T09:16:05.070Z"/>
	<Row StudyFormId="885" FormId="569" FormTitle="Flacker-Kiely" StudyName="TEST" Repeatable="1" SurveyStatus="Design" HideComment="0" LastUpdate="2016-08-15T12:35:49.197Z"/>
	<Row StudyFormId="886" FormId="519" FormTitle="Pasientskjema - Synacthenstudien" StudyName="ENDO" Repeatable="0" SurveyStatus="Open" HideComment="0" LastUpdate="2016-06-06T13:46:59.887Z"/>
	<Row StudyFormId="887" FormId="639" FormTitle="Samtykkekomptetanse" StudyName="TEST" Repeatable="1" SurveyStatus="Design" HideComment="0" LastUpdate="2016-10-07T12:33:47.430Z"/>
	<Row StudyFormId="888" FormId="731" FormTitle="Grunndata lipid" StudyName="LIPID" Repeatable="1" SurveyStatus="Design" HideComment="0" LastUpdate="2016-10-27T14:07:03.823Z"/>
	<Row StudyFormId="889" FormId="732" FormTitle="PROM Diabetes" StudyName="NDV.PROMS" Repeatable="1" SurveyStatus="Design" HideComment="0" LastUpdate="2016-11-04T13:13:51.730Z"/>
	<Row StudyFormId="890" FormId="298" FormTitle="PAID - Problemområder i Diabetes" StudyName="NDV.PROMS" Repeatable="1" SurveyStatus="Open" HideComment="0" LastUpdate="2016-11-02T09:29:15.970Z"/>
	<Row StudyFormId="891" FormId="797" FormTitle="Perceived Competence in Diabetes Scale" StudyName="NDV.PROMS" Repeatable="1" SurveyStatus="Design" HideComment="0" LastUpdate="2016-11-02T09:28:44.460Z"/>
	<Row StudyFormId="892" FormId="880" FormTitle="WHO-5 Well-being index" StudyName="NDV.PROMS" Repeatable="1" SurveyStatus="Design" HideComment="0" LastUpdate="2016-11-04T13:10:52.280Z"/>
	<Row StudyFormId="893" FormId="881" FormTitle="MMSE-NR3" StudyName="ALLRATE" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-12-01T14:20:34.240Z"/>
	<Row StudyFormId="894" FormId="881" FormTitle="MMSE-NR3" StudyName="GBD" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-12-01T14:20:34.240Z"/>
	<Row StudyFormId="895" FormId="881" FormTitle="MMSE-NR3" StudyName="ARCHETYPES" Repeatable="1" SurveyStatus="Open" HideComment="1" LastUpdate="2016-12-01T14:20:34.240Z"/>
</MetaStudyForm>
